Eton Pharmaceuticals, Inc. (ETON) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 7.41M | -11.55M | 12.03M | 7.96M | 2.09M | -765K | 2.95M | 1.25M | -2.47M | 387K | 873K | 7.1M |
| Operating CF Margin % | 30.52% | -54.28% | 53.55% | 42.05% | 12.09% | -6.57% | 28.59% | 13.83% | -31.04% | 5.29% | 12.42% | 59.21% |
| Operating CF Growth % | 254.31% | -1409.93% | 307.38% | 534.18% | 184.51% | -297.67% | 238.14% | -82.33% | -59.75% | -86.37% | 151.26% | 188.62% |
| Net Income | 1.55M | 1.48M | -1.93M | -2.58M | -1.57M | -598K | 627K | -3.04M | -811K | -2.26M | -579K | 4.56M |
| Depreciation & Amortization | 1.13M | 1.02M | 1.01M | 1M | 1.01M | 355K | 278K | 261K | 277K | 275K | 202K | 211K |
| Stock-Based Compensation | 0 | 1.12M | 1.09M | 2.1M | 1.2M | 782K | 722K | 840K | 821K | 750K | 730K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.23M | 2.2M | 1.51M | 1.27M | 1.45M | 1.06M | 39K | 59K | 0 | 27K | 29K | 817K |
| Working Capital Changes | 2.49M | -17.37M | 10.34M | 6.17M | -4K | -2.36M | 1.29M | 3.14M | -2.76M | 1.59M | 491K | 1.52M |
| Change in Receivables | -1.65M | 1.32M | 1.37M | 1.95M | -11.04M | -939K | -717K | -633K | -829K | 84K | -411K | -210K |
| Change in Inventory | 1.41M | -581K | 5.61M | -11.38M | 468K | -283K | 130K | 250K | -1.41M | 140K | -235K | -379K |
| Change in Payables | 2.51M | -3.28M | 2.12M | 7.26M | 705K | 1.48M | 552K | -130K | 414K | 105K | -589K | 1.07M |
| Cash from Investing | -15.07M | -49K | -284K | 0 | 0 | -38.13M | 0 | 0 | -1.88M | -775K | 0 | 0 |
| Capital Expenditures | -15.07M | -49K | -284K | 0 | 0 | -8.13M | 0 | 0 | -1.88M | -775K | 0 | 0 |
| CapEx % of Revenue | 62.12% | 0.23% | 1.26% | - | - | 69.82% | - | - | 23.63% | 10.6% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -30M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.39M | 421K | 0 | 0 | 394K | 33.57M | -385K | -216K | -378K | -294K | -368K | -246K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 25.31M | -385K | -385K | -385K | -385K | -385K | -385K |
| Equity Issued (Net) | 1.39M | 421K | 0 | 0 | 394K | 8.02M | 0 | 169K | 7K | -90K | 17K | 139K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 248K | 0 | 0 | 0 | 181K | 0 | 0 |
| Net Change in Cash | -6.28M | -11.18M | 11.74M | 7.96M | 2.48M | -5.33M | 2.57M | 1.04M | -4.73M | -682K | 504K | 6.86M |
| Free Cash Flow | 7.33M | -11.6M | 11.74M | 7.96M | 2.09M | -777K | 2.95M | 1.25M | -4.36M | -388K | 873K | 7.1M |
| FCF Margin % | 30.21% | -54.51% | 52.28% | 42.05% | 12.09% | -6.67% | 28.59% | 13.83% | -54.67% | -5.31% | 12.42% | 59.21% |
| FCF Growth % | 250.72% | -1392.92% | 297.76% | 534.18% | 147.99% | -100.26% | 238.14% | -82.33% | -181.33% | -113.72% | 123.58% | 317.82% |
| FCF per Share | 0.23 | -0.43 | 0.44 | 0.30 | 0.08 | -0.03 | 0.11 | 0.05 | -0.17 | -0.02 | 0.03 | 0.27 |
| FCF Conversion (FCF/Net Income) | 4.77x | -7.79x | -6.24x | -3.08x | -1.33x | 1.28x | 4.71x | -0.41x | 3.05x | -0.17x | -1.51x | 1.56x |
| Interest Paid | 0 | 930K | 1.54M | 210K | 642K | 0 | 163K | 0 | 0 | 204K | 0 | 0 |
| Taxes Paid | 0 | 1K | 28K | 81K | 8K | 0 | 181K | 0 | 0 | 247K | 0 | 0 |